Churchill Downs Incorporated (CDI) on July 31 became the 24th racetrack entity in the United States to commit to making a contribution to the Racing Medication and Testing Consortium (RMTC).

This commitment is part of the RMTC's annual track fundraising campaign, in which it hopes to raise at least $200,000 in contributions from tracks across the country. Bill Carstanjen, CDI president, linked the contribution to the RMTC's continuing efforts in drug research and equine advocacy.

"This support is part of our ongoing efforts to make meaningful contributions that will improve the state of horse racing in America," Carstanjen said. "RMTC is a positive and strong voice in our industry and CDI shares their goal of helping to ensure the health and welfare of racehorses and participants."

Churchill Downs Incorporated joins other multi-track owners like New York Racing Association, Stronach Group, and Global Gaming in committing to help fund the RMTC in 2014